Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Pruritus | Pruritus | postmarketing | x | x | |
| Erythema | Erythema | postmarketing | x | x | |
| Skin hyperpigmentation | Skin hyperpigmentation | postmarketing | x | x | |
| Skin exfoliation | Skin exfoliation | postmarketing | x | x | |
| Dermatitis contact | Dermatitis contact | x | x | ||
| Application site reaction | Application site reaction | x | |||
| Dry skin | Dry skin | x | x | ||
| Skin burning sensation | Skin burning sensation | x | x | ||
| Pain of skin | Skin tenderness | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Sensitisation | x | x | |||
| Tinea pedis | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |